We have raised 100 million yen in a Pre-Series A funding round, with OSAKA University Venture Capital Co., Ltd. (OUVC) as the lead investor.

With the funds raised in this round, we will advance the development of a software-based medical device that supports early screening of musculoskeletal disorders—one of the primary causes of gait difficulties—in clinical settings. In addition, we will work on the development and validation of a business model geared toward social implementation following regulatory approval, as well as strengthen our team through recruitment and organizational enhancement.
https://prtimes.jp/main/html/rd/p/000000001.000151131.html